AGI vs. NBIX
AGI (Alamos Gold Inc.) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. AGI operates in Gold (Basic Materials), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, AGI returned 12.25%/yr vs 12.71%/yr for NBIX. Their 0.07 correlation means their historical movements had little consistent relationship.
Performance
AGI vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AGI achieves a -27.72% return, which is significantly lower than NBIX's 17.61% return. Both investments have delivered pretty close results over the past 10 years, with AGI having a 12.25% annualized return and NBIX not far ahead at 12.71%.
AGI
- 1D
- -2.01%
- 1M
- -8.18%
- 6M
- -24.43%
- YTD
- -27.72%
- 1Y
- 14.93%
- 3Y*
- 33.49%
- 5Y*
- 28.93%
- 10Y*
- 12.25%
- ALL TIME*
- 16.33%
NBIX
- 1D
- -10.08%
- 1M
- -0.58%
- 6M
- 22.59%
- YTD
- 17.61%
- 1Y
- 30.08%
- 3Y*
- 17.27%
- 5Y*
- 12.34%
- 10Y*
- 12.71%
- ALL TIME*
- 9.11%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $133.64M | $126.71M | $144.32M | |
| $278.93M | $232.17M | $211.02M |
AGI vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AGI Alamos Gold Inc. | -27.72% | 109.93% | 37.72% | 34.33% | 33.11% | -11.00% | 46.75% | 68.42% | -44.49% | -4.57% |
NBIX Neurocrine Biosciences, Inc. | 17.61% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -7.96% | 100.49% |
Correlation
The correlation between AGI and NBIX is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.09 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.11 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.07 |
Correlation (All Time) Calculated using the full available price history since Mar 17, 2003 | 0.07 |
Fundamentals
AGI:
$11.69B
NBIX:
$16.77B
AGI:
$2.76
NBIX:
$6.84
AGI:
10.07
NBIX:
24.39
AGI:
0.07
NBIX:
0.48
AGI:
5.32
NBIX:
5.10
AGI:
2.44
NBIX:
4.35
AGI:
$2.21B
NBIX:
$3.37B
AGI:
$1.33B
NBIX:
$3.31B
AGI:
$1.75B
NBIX:
$940.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AGI vs. NBIX — Risk / Return Rank
AGI
NBIX
AGI vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alamos Gold Inc. (AGI) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AGI | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.63 | ||
| Sortino ratioReturn per unit of downside risk | -0.66 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.19 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 1.45 | -1.14 |
| Martin ratioReturn relative to average drawdown | 0.70 | 3.18 | -2.48 |
Loading charts...
Drawdowns
AGI vs. NBIX - Drawdown Comparison
The maximum AGI drawdown since its inception was -88.13%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for AGI and NBIX.
Loading charts...
Drawdown Indicators
| AGI | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.13% | -97.21% | +9.08% |
Max Drawdown (1Y)Largest decline over 1 year | -49.60% | -20.90% | -28.70% |
Max Drawdown (3Y)Largest decline over 3 years | -49.60% | -42.89% | -6.71% |
Max Drawdown (5Y)Largest decline over 5 years | -49.60% | -42.89% | -6.71% |
Max Drawdown (10Y)Largest decline over 10 years | -67.81% | -46.39% | -21.42% |
Current DrawdownCurrent decline from peak | -49.60% | -10.08% | -39.52% |
Average DrawdownAverage peak-to-trough decline | -37.77% | -43.66% | +5.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.26% | 9.47% | +11.79% |
Volatility
AGI vs. NBIX - Volatility Comparison
The current volatility for Alamos Gold Inc. (AGI) is 11.71%, while Neurocrine Biosciences, Inc. (NBIX) has a volatility of 14.12%. This indicates that AGI experiences smaller price fluctuations and is considered to be less risky than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AGI | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.71% | 14.12% | -2.41% |
Volatility (6M)Calculated over the trailing 6-month period | 44.49% | 26.01% | +18.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.01% | 33.74% | +20.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.86% | 33.17% | +8.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.43% | 39.18% | +9.25% |
Dividends
AGI vs. NBIX - Dividend Comparison
AGI's dividend yield for the trailing twelve months is around 0.47%, while NBIX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGI Alamos Gold Inc. | 0.47% | 0.26% | 0.54% | 0.74% | 0.99% | 1.30% | 0.74% | 0.66% | 0.56% | 0.31% | 0.29% | 1.22% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
AGI vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Alamos Gold Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AGI vs. NBIX - Profitability Comparison
AGI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Alamos Gold Inc. reported a gross profit of 342.96M and revenue of 579.01M. Therefore, the gross margin over that period was 59.2%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Neurocrine Biosciences, Inc. reported a gross profit of 935.80M and revenue of 959.00M. Therefore, the gross margin over that period was 97.6%.
AGI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Alamos Gold Inc. reported an operating income of 345.99M and revenue of 579.01M, resulting in an operating margin of 59.8%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Neurocrine Biosciences, Inc. reported an operating income of 151.50M and revenue of 959.00M, resulting in an operating margin of 15.8%.
AGI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Alamos Gold Inc. reported a net income of 263.53M and revenue of 579.01M, resulting in a net margin of 45.5%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Neurocrine Biosciences, Inc. reported a net income of 144.40M and revenue of 959.00M, resulting in a net margin of 15.1%.
Frequently Asked Questions
AGI and NBIX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIX has higher volatility (14.12%) compared to AGI (11.71%). In terms of maximum drawdown, AGI dropped -88.13% vs NBIX's -97.21%.
NBIX currently has the higher Sharpe Ratio (0.91 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AGI and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer